• +1-646-491-9876
    • +91-20-67278686

    Search

    Global Antivenom Market: By Antivenom Type (Monovalent, Bivalent, Trivalent, Tetravalent, and Polyvalent), By Reptile Type (Snakes, Scorpions, Spiders, and Others), By Immunoglobulin Type (Homologous and Heterologous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)-Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

    Global Antivenom Market: By Antivenom Type (Monovalent, Bivalent, Trivalent, Tetravalent, and Polyvalent), By Reptile Type (Snakes, Scorpions, Spiders, and Others), By Immunoglobulin Type (Homologous and Heterologous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)-Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

    • Report Code ID: RW00011411982
    • Category Life Sciences
    • No. of Pages 197
    • Publication Month Oct-17
    • Publisher Name Precision Business Insights
    Global Antivenom Market Report Description:
    Global antivenom market report gives comprehensive outlook on antivenom products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on antivenom market gives historical, current, and future market sizes (US$ Mn) on the basis of antivenom type, reptile type, immunoglobulin type, distribution channel, and geographic regions. This report studies antivenom market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, antivenom market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed antivenom market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the antivenom market report include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers who are engaged in usage and advocacy of antivenom products.
    Global Antivenom Market:
    Global antivenom market was valued around US$ 1,100 Mn in 2016 and poised to grow around 6.0% CAGR over 2017-2023.
    Competition Assessment
    Key players profiles in the global antivenom market include:

    -Vins Bioproducts Limited (India)
    -Bharat Serum and Vaccines Limited (India)
    -CSL Limited (Victoria)
    -Rare Disease Therapeutics, Inc. (U.S.)
    -F. Hoffmann-La Roche AG (Switzerland)
    -Instituto Bioclon, S.A. de C.V.(Mexico)
    -Incepta Vaccine Ltd. (Bangladesh)
    -BTG Plc (UK)
    -Merck & Co., Inc. (U.S)
    -Pfizer Inc. (U.S.)


    Key Features of the Report:

    -The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
    -The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
    -The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
    -The report tracks recent innovations, key developments and startup's details that are actively working in the market
    -The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
    -The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market


    Detailed Segmentation

    By Antivenom Type
    o Monovalent
    o Bivalent
    o Trivalent
    o Tetravalent
    o Polyvalent

    By Reptile Type
    o Snakes
    o Scorpions
    o Spiders
    o Others

    By Immunoglobulin Type
    o Homologous
    o Heterologous

    By Distribution Channel
    o Hospital Pharmacies
    o Retail Pharmacies
    o Others

    Geography
    o North America
    -U.S
    -Canada
    o Europe
    -Germany
    -France
    -U.K
    -Italy
    -Spain
    -Russia
    -Poland
    -Rest of Europe
    o Asia-Pacific
    -Japan
    -China
    -India
    -Australia & New Zealand
    -ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
    -South Korea
    -Rest of Asia-Pacific
    o Latin America
    -Brazil
    -Mexico
    -Argentina
    -Venezuela
    -Rest of Latin America
    o Middle East and Africa (MEA)
    -Gulf Cooperation Council (GCC) Countries
    -Israel
    -South Africa
    -Rest of MEA
    Table of Contents

    1. Executive summary
    2. Global Antivenom Market Introduction
    2.1. Global Antivenom Market-Taxonomy
    2.2. Global Antivenom Market-Definitions
    2.2.1. Antivenom Type
    2.2.2. Reptile Type
    2.2.3. Immunoglobulin Type
    2.2.4. Distribution Channel
    2.2.5. Region
    3. Global Antivenom Market Dynamics
    3.1. Drivers
    3.2. Restraints
    3.3. Opportunities/Unmet Needs of the Market
    3.4. Trends
    3.5. Global Antivenom Market Dynamics-Factors Impact Analysis
    3.6. Global Antivenom Market Dynamics-Regulations
    3.6.1. U.S
    3.6.2. Europe
    3.6.3. Japan
    3.6.4. China
    3.7. Global Antivenom Market-Product Innovations

    3.9. Price Analysis
    3.10. Technological Landscape
    3.11. Value Chain Analysis
    3.12. Competitor Landscape
    3.13. Recent Flexible e-paper Product Launches
    3.14. Funds raised by the Start-ups
    3.15. Collaborations and acquisitions in market
    4. Global Antivenom Market Analysis 2017-2025
    4.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
    4.3. Market Opportunity Analysis
    5. Global Antivenom Market, By Antivenom Type, 2017-2023
    5.1. Monovalent
    5.1.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    5.1.3. Market Opportunity Analysis
    5.2. Bivalent
    5.2.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    5.2.3. Market Opportunity Analysis
    5.3. Trivalent
    5.3.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    5.3.3. Market Opportunity Analysis
    5.4. Tetravalent
    5.4.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    5.4.3. Market Opportunity Analysis
    5.5. Polyvalent
    5.5.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    5.5.3. Market Opportunity Analysis
    6. Global Antivenom Market , By Reptile Type, 2017-2023
    6.1. Snakes
    6.1.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    6.2.3. Market Opportunity Analysis
    6.2. Scorpions
    6.2.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    6.2.3. Market Opportunity Analysis
    6.3. Others
    6.3.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    6.2.3. Market Opportunity Analysis
    7. Global Antivenom Market Forecast, By Immunoglobulin Type, 2017-2023
    7.1. Homologous
    7.1.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    7.1.3. Market Opportunity Analysis
    7.2. Heterologus
    7.2.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    7.2.3. Market Opportunity Analysis
    8. Global Antivenom Market Forecast, By Distribution channel, 2017-2023
    8.1. Hospital Pharmacies
    8.1.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    8.1.3. Market Opportunity Analysis
    8.2. Retail Pharmacies
    8.2.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    8.2.3. Market Opportunity Analysis
    9. Global Antivenom Market Forecast, By Region, 2017-2023
    9.1. North America
    9.1.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    9.1.3. Market Opportunity Analysis
    9.2. Europe
    9.2.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    9.2.3. Market Opportunity Analysis
    9.3. Asia-Pacific
    9.3.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    9.3.3. Market Opportunity Analysis
    9.4. Latin America
    9.4.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    9.4.3. Market Opportunity Analysis
    9.5. Middle East & Africa
    9.5.1. Market Analysis and Forecast, 2017-2025 (Revenue, USD Mn)
    9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
    9.5.3. Market Opportunity Analysis
    9.6. Global Antivenom Market-Opportunity Analysis Index, By Antivenom Type,
    Reptile Type, Immunoglobulin Type, Distribution Channel and Region, 2017-2025
    10. North America Antivenom Market Analysis 2017-2023
    10.1.1. Antivenom Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y
    Growth (%), and Market Share (%)
    10.1.1.1. Monovalent
    10.1.1.2. Bivalent
    10.1.1.3. Trivalent
    10.1.1.4. Tetravalent
    10.1.1.5. Polyvalent
    10.1.2. Reptile Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    10.1.2.1. Snakes
    10.1.2.2. Scorpions
    10.1.2.3. Others
    10.1.3. Immunoglobulin Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y
    Growth (%), and Market Share (%)
    10.1.3.1. Homologous
    10.1.3.2. Heterologous
    10.1.4.Distribution Channel Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    10.1.4.1. Hospital Pharmacies
    10.1.4.2. Retail Pharmacies
    10.1.4.5. Others
    10.1.5. Country Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    10.1.5.1. U.S
    10.1.5.2. Canada
    10.1.6. North America Antivenom Market-Opportunity Analysis Index, By Antivenom Type,
    Reptile Type, Immunoglobulin Type, Distribution Channel, and Country, 2017-2025
    10.1.7. North America Antivenom Market Dynamics-Trends
    11. Europe Antivenom Market Analysis 2017-2023
    11.1.1.Antivenom Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Monovalent
    11.1.1.2. Bivalent
    11.1.1.3. Trivalent
    11.1.1.4. Tetravalent
    11.1.1.5. Polyvalent
    11.1.2.Reptile Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    11.1.2 Snakes
    11.1.2.1. Scorpions
    11.1.2.2. Others
    11.1.3.Immunoglobulin Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    -o-Y Growth (%), and Market Share (%)
    11.1.3.1. Homologous
    11.1.3.2. Heterologus
    11.1.4.Distribution Channel Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    11.1.4.1. Hospital Pharmacies
    11.1.4.2. Retail Pharmacies
    11.1.4.5. Others
    11.1.5. Country Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Italy
    11.1.5.5. Spain
    11.1.5.6. Poland
    11.1.5.7. Russia
    11.1.5.8. Rest of Europe
    11.1.6. Europe Antivenom Market-Opportunity Analysis Index, By Antivenom Type,
    Reptile Type, Immunoglobulin Type, Distribution Channel, and Country, 2017-2025
    11.1.7. Europe Antivenom Market Dynamics-Trends
    12. Asia-Pacific Antivenom Market Analysis 2017-2023
    12.1.1.Antivenom Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Monovalent
    12.1.1.2. Bivalent
    12.1.1.3. Trivalent
    12.1.1.4. Tetravalent
    12.1.1.5. Polyvalent
    12.1.2. Reptile Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    12.1.2.1. Snakes
    12.1.2.2. Scorpions
    12.1.2.3. Others
    12.1.3. Immunoglobulin Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    12.1.3.1. Homologous
    12.1.3.2. Heterologous
    12.1.4. Distribution Channel Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    12.1.4.1. Hospital Pharmacies
    12.1.4.2. Retail Pharmacies
    12.1.4.5. Others
    12.1.5. Country Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of APAC
    12.1.6. Asia-Pacific Antivenom Market-Opportunity Analysis Index, By Antivenom Type,
    Reptile Type, Immunoglobulin Type, Distribution Channel, and Country, 2017-2025
    12.1.7. Asia-Pacific Antivenom Market Dynamics-Trends
    13. Latin America Antivenom Market Analysis 2017-2023
    13.1.1. Antivenom Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y
    Growth (%), and Market Share (%)
    13.1.1.1. Monovalent
    13.1.1.2. Bivalent
    13.1.1.3. Trivalent
    13.1.1.4. Tetravalent
    13.1.1.5. Polyvalent
    13.1.2. Reptile Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y
    Growth (%), and Market Share (%)
    13.1.2.1. Snakes
    13.1.2.2. Scorpions
    13.1.2.3. Others
    13.1.3. Immunoglobulin Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    13.1.3.1. Homologous
    13.1.3.2. Heterologous
    13.1.4. Distribution Channel Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    13.1.4.1. Hospital Pharmacies
    13.1.4.2. Retail Pharmacies
    13.1.4.5. Others
    13.1.5. Country Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
    13.1.6. Latin America Antivenom Market-Opportunity Analysis Index, By Antivenom Type,
    Reptile Type, Immunoglobulin Type, Distribution Channel, and Country, 2017-2025
    13.1.7. Latin America Antivenom Market Dynamics-Trends
    14. Middle East & Africa Antivenom Market Analysis 2017-2023
    14.1.1.Antivenom Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y
    Growth (%), and Market Share (%)
    14.1.1.1. Monovalent
    14.1.1.2. Bivalent
    14.1.1.3. Trivalent
    14.1.1.4. Tetravalent
    14.1.1.5. Polyvalent
    14.1.1.6.
    14.1.1.7.
    14.1.1.9.
    14.1.2.Reptile Type Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    14.1.2.1. Snakes
    14.1.2.2. Scorpions
    14.1.2.3. Others
    14.1.3.Immunoglobulin Type Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    14.1.3.1. Homologous
    14.1.3.2. Heterologous
    14.1.4.Distribution Channel Analysis Forecast (2017-2025) by Revenue (USD Mn),
    Y-o-Y Growth (%), and Market Share (%)
    14.1.4.1. Hospital Pharmacies
    14.1.4.2. Retail Pharmacies
    14.1.4.5. Others
    14.1.5. Country Analysis Forecast (2017-2025) by Revenue (USD Mn), Y-o-Y Growth (%),
    and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
    14.1.6. Middle East & Africa Antivenom Market-Opportunity Analysis Index, By Antivenom
    Type, Reptile Type, Immunoglobulin Type, Distribution Channel, and Country, 2017-2025
    14.1.7. Middle East & Africa Dynamics-Trends
    15. Competition Landscape
    15.1. Strategic Dashboard of Top Market Players
    15.2. Company Profiles (Introduction, Financial Analysis Product & Service Offerings,
    Key Developments, Strategies, and SWOT Analysis)
    15.2.1. Vins Bioproducts Limited (India)
    15.2.2. Bharat Serum and Vaccines Limited (India)
    15.2.3. CSL Limited (Victoria)
    15.2.4. Rare Disease Therapeutics, Inc. (U.S.)
    15.2.5. F. Hoffmann-La Roche AG (Switzerland)
    15.2.6. Instituto Bioclon, S.A. de C.V.(Mexico)
    15.2.7. Incepta Vaccine Ltd. (Bangladesh)
    15.2.8. BTG Plc (UK)
    15.2.9. Merck & Co., Inc. (U.S)
    15.2.10. Pfizer Inc. (U.S.)
    16. Research Methodology
    17. Key Assumptions and Acrony
    Vins Bioproducts Limited (India), Bharat Serum and Vaccines Limited (India), CSL Limited (Victoria), Rare Disease Therapeutics, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Instituto Bioclon, S.A. de C.V.(Mexico), Incepta Vaccine Ltd. (Bangladesh), BTG Plc (UK), Merck & Co., Inc. (U.S), Pfizer Inc. (U.S.)

    Request for Sample

    Report Url http://www.reportsweb.com//global-antivenom-market-and-forecast-2017-2023&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//global-antivenom-market-and-forecast-2017-2023&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//global-antivenom-market-and-forecast-2017-2023&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments